Annerieke R. Sierksma
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
C1q and immunoglobulins mediate activity-dependent synapse loss in the adult brain.
Journal: Science (New York, N.Y.)
Published: July 09, 2026
Author Correction: Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's disease.
Journal: Nature neuroscience
Published: February 17, 2026
A versatile mouse model to advance human microglia transplantation research in neurodegenerative diseases.
Journal: Molecular neurodegeneration
Published: November 15, 2024
The MIR-NAT MAPT-AS1 does not regulate Tau expression in human neurons.
Journal: PloS one
Published: July 25, 2024
Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response.
Journal: Cell reports
Published: March 07, 2024
Intestinal macrophages modulate synucleinopathy along the gut-brain axis.
Journal: Nature
Published: October 23, 2023
MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease.
Journal: Science (New York, N.Y.)
Published: September 14, 2023
microRNA-132 regulates gene expression programs involved in microglial homeostasis.
Journal: iScience
Published: December 22, 2022
Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's disease.
Journal: Nature neuroscience
Published: July 05, 2022
From Junk to Function: LncRNAs in CNS Health and Disease.
Journal: Frontiers in molecular neuroscience
Published: May 25, 2021
Identifying individuals with high risk of Alzheimer's disease using polygenic risk scores.
Journal: Nature communications
Published: December 28, 2020
Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets.
Journal: Science (New York, N.Y.)
Published: October 02, 2020
Last Updated: 09/26/2026